Author | Year of collection | Case number | Cancer subsite | Treatment | Survival rate | Organ preservation rate |
---|---|---|---|---|---|---|
VALCSG[11] | Â | 332 | Stage III/IV LAx | Surgery | 68% at 2 yr | Â |
 |  |  |  | Induction C/T + RT | 68% at 2 yr | 64% at 2 yr |
Malone et al.[25] | 1993-2000 | 40 | Stage III/IV BOT | OP+adj-CCRT | 74.7% at 2 yr | - |
Sewnaik et al.[5] | 1985-1994 | 893 | HPx | Surgery and RT | 32% at 5 yr | Â |
1989-2002 | 222 | All head and neck | CCRT | 65.7% at 5 yr | 62.2% at 5 yr | |
Soo et al.[4] | Â | 119 | All head and neck | Surgery | 50% at 3 yr# | Â |
 |  |  |  | CCRT | 40% at 3 yr# | 45% at 3 yr |
Hanna et al.[7] | 1996-2002 | 127 | OPx, LAx, HPx, OC | CCRT | 57% at 3 yr | - |
Urba et al.[6] | Â | 59 | BOT, HPx | Induction C/T + CCRT | 64% at 3 yr | 52% at 3 yr |
Current series | 1994-2004 | 395 | HPx | Surgery | 18.8% at 5 yr | Â |
 |  |  |  | CCRT | 27% at 5 yr | 44.8% at 3 yr 37% at 4 yr |